Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic L

Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics, Cardiac Bionics)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Artificial Vital Organs are man-made devices that are created to work like original diseases organ or to restore a specific function of that organ. These devices are implanted at the site of the diseased organ in the patient. Medical bionics is the study of application of mechanics and electronics for the replacement of a limb or other part of a functional organ that is mechanically powered. Artificial organs can be an artificial heart, artificial kidney, artificial pancreas and others. An artificial organ consists of different parts that mimic functions of the original organ. For instance, artificial pancreas systems comprise of devices that are already used in diabetes management such as Continuous glucose monitoring (CGM) device, insulin pump, blood glucose device (BGD), and digital control device with control algorithm. Artificial pancreas systems are compatible with existing pumps and CGMs and its control functions can be integrated into a regular smartphone.

Restraints of the Global Artificial Vital Organs and Medical Bionics Market

Major factors hampering the growth of the Artificial Vital Organs and Medical Bionics market during the forecast period constitutes of criticism associated with artificial organ transplant, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the global Artificial Vital Organs and Medical Bionics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Artificial Vital Organs and Medical Bionics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Artificial Vital Organs and Medical Bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
  • Global Artificial Vital Organs and Medical Bionics Market, By Type:
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • Global Artificial Vital Organs and Medical Bionics Market, By Geography:
  • North America
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Type
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • SynCardia Systems, LLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • BiVACOR
  • CARMAT
  • Cleveland Heart
  • Jarvik Heart
  • MyLVAD
  • Cirtec Medical Systems
  • Thoratec Corporation
  • Abbott Diabetes Care, Inc.
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • Other Major Players
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. Global Artificial Vital Organs and Medical Bionics Market, By Type, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Artificial Vital Organs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
5. Global Artificial Vital Organs and Medical Bionics Market, By Regions, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
6. Competitive Landscape
Company Profiles
SynCardia Systems, LLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BiVACOR
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
CARMAT
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cleveland Heart
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Jarvik Heart
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
MyLVAD
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cirtec Medical Systems
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thoratec Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Diabetes Care, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abiomed, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Asahi Kasei Medical Co., Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cyberonics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Edwards Lifesciences Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Other Major Players
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
7. Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 34 figures on “Artificial Vital Organs and Medical Bionics Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings